Skip to main content
. 2026 Feb 9;12:1646323. doi: 10.3389/fmed.2025.1646323

Table 2.

Differential metabolites in the urine of patients with cirrhosis.

No. Rt(min) m/z Formula Metabolite HMDB ID VIP p value Trend
DIS vs. CON
1 4.64 316.25 C17H33NO4 decanoylcarnitine HMDB0000651 1.02 0.03 down
2 7.22 313.27 C19H38O4 MG(0:0/16:0/0:0) HMDB0011533 1.63 0.00 up
3 4.41 302.23 C16H31NO4 6-methyloctanoylcarnitine HMDB0241048 1.36 0.00 down
4 2.87 222.08 C11H13NO4 N-acetyl-L-tyrosine HMDB0000866 1.93 0.00 up
5 4.58 330.26 C18H35NO4 8-methyldecanoylcarnitine HMDB0240799 1.16 0.02 down
6 4.12 302.23 C16H31NO4 5-methyloctanoylcarnitine HMDB0241049 1.43 0.00 down
7 4.22 591.32 C33H42N4O6 urobilin HMDB0004160 2.02 0.00 up
8 4.52 655.28 C36H38N4O8 coproporphyrin III HMDB0000570 1.66 0.00 up
9 4.29 655.28 C36H38N4O8 coproporphyrin I HMDB0000643 1.67 0.00 up
10 2.59 209.09 C10H12N2O3 L-kynurenine HMDB0000684 1.17 0.00 up
11 3.80 206.08 C11H11NO3 indole-3-lactic acid HMDB0000671 1.43 0.00 up
12 1.43 204.13 C9H18NO4 o-acetylcarnitine HMDB0000201 1.05 0.03 up
13 3.30 244.15 C12H21NO4 2-tiglylcarnitine HMDB0241658 1.63 0.00 down
14 4.05 464.30 C26H43NO6 glycocholic acid HMDB0000138 1.52 0.00 up
15 1.24 130.09 C6H11NO2 pipecolic acid HMDB0000070 1.10 0.03 up
16 3.93 130.07 C4H9N3O2 creatine HMDB0000064 1.03 0.01 up
17 1.67 262.16 C12H23NO5 5-hydroxypentanoylcarnitine HMDB0241655 1.09 0.00 down
18 4.49 491.30 C28H44O7 24(28)-dehydromakisterone HMDB0302988 2.02 0.00 up
19 3.55 318.19 C15H27NO6 3-methylheptanedioylcarnitine HMDB0241046 1.28 0.00 up
20 3.66 340.18 C17H25NO6 deca-3,5,7-trienedioylcarnitine HMDB0241129 2.36 0.00 down
21 2.55 302.16 C14H23NO6 hept-4-enedioylcarnitine HMDB0241688 1.53 0.00 down
22 3.81 204.07 C11H11NO3 indolelactic acid HMDB0000671 2.02 0.00 up
23 3.79 329.21 C21H30O4 corticosterone HMDB0001547 1.75 0.00 down
24 2.53 194.05 C9H9NO4 alpha-hydroxyhippuric acid HMDB0002404 1.06 0.02 down
25 0.85 264.12 C9H17N3O6 creatine riboside HMDB0240254 1.44 0.00 up
26 1.51 314.12 C14H19NO7 tyramine glucuronide HMDB0010328 1.12 0.03 up
27 7.89 297.28 C19H36O2 cis-10-nonadecenoic acid HMDB0013622 3.32 0.00 up
28 3.35 318.19 C15H27NO6 octanedioylcarnitine HMDB0241733 1.11 0.00 up
29 5.94 437.26 C21H43O7P lysoPA(18:0/0:0) HMDB0007854 1.63 0.00 up
30 3.74 539.25 C27H41O9P PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0) HMDB0266564 2.18 0.00 down
31 3.96 627.37 C33H57O9P PA(20:4(5Z,8Z,11Z,13E)-OH(15S)/10:0) HMDB0262660 1.38 0.00 up
32 2.80 340.10 C15H17NO8 5-hydroxy-6-methoxyindole glucuronide HMDB0010363 1.69 0.00 down
33 4.72 386.29 C21H39NO5 3-hydroxy-cis-5-tetradecenoylcarnitine HMDB0013330 1.22 0.00 up
34 3.92 398.25 C21H35NO6 tetradeca-9,11-dienedioylcarnitine HMDB0241391 1.20 0.00 up
35 4.01 329.21 C21H30O4 reichsteins Substance S HMDB0000015 1.77 0.00 down
36 5.65 435.24 C21H41O7P LysoPA(18:1(9Z)/0:0) HMDB0007855 1.27 0.00 up
37 3.71 184.10 C9H15NO3 3-hepteneoylglycine HMDB0094729 1.52 0.00 down
38 4.35 199.13 C11H20O3 2-hydroxyundec-8-enoic acid HMDB0340607 1.38 0.00 up
39 1.62 260.15 C12H21NO5 4-oxopentanoylcarnitine HMDB0241664 1.06 0.01 down
40 3.91 298.20 C16H27NO4 nona-3,6-dienoylcarnitine HMDB0241762 1.82 0.00 down
41 4.13 157.12 C9H18O2 isopropyl hexanoate HMDB0040430 1.01 0.00 down
42 3.31 305.03 C11H14O8S 4-hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulfate HMDB0059978 1.36 0.02 down
43 2.03 262.16 C12H23NO5 3-hydroxyisovalerylcarnitine HMDB0061189 1.06 0.01 down
44 3.97 593.33 C33H42N4O6 urobilinogen HMDB0004158 1.53 0.00 up
45 3.69 316.21 C16H29NO5 6-hydroxynon-4-enoylcarnitine HMDB0241753 1.06 0.01 down
46 1.56 240.11 C9H13N5O3 dihydrobiopterin HMDB0000038 1.11 0.00 down
47 3.48 300.18 C15H25NO5 3-hydroxyocta-2,5-dienoylcarnitine HMDB0241723 1.29 0.00 down
48 3.75 331.23 C21H30O3 17 alpha-Hydroxyprogesterone HMDB0000374 1.21 0.00 down
49 4.27 414.30 C26H43NO5 glycoursodeoxycholic acid HMDB0000708 1.12 0.02 up
50 4.10 204.09 C8H15NO6 N-acetylmannosamine HMDB0001129 1.16 0.02 up
51 3.48 182.08 C9H13NO3 normetanephrine HMDB0000819 1.43 0.00 down